Patents by Inventor François SAUTEL

François SAUTEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Trilobine and its natural analogs for use as a drug
    Patent number: 10517863
    Abstract: Trilobine and its natural triple-bridged bisbenzylisoquinoline alkaloidal analogues as DNMT inhibitors for use as a drug for the treatment of cancer and neurological diseases and for cell reprogramming, in particular to prime for chemotherapy or immunotherapy.
    Type: Grant
    Filed: October 3, 2016
    Date of Patent: December 31, 2019
    Assignees: PIERRE FABRE MEDICAMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Yoann Menon, Christophe Long, François Sautel, Paola B. Arimondo
  • TRILOBINE AND ITS NATURAL ANALOGS FOR USE AS A DRUG
    Publication number: 20180280379
    Abstract: Trilobine and its natural triple-bridged bisbenzylisoquinoline alkaloidal analogues as DNMT inhibitors for use as a drug for the treatment of cancer and neurological diseases and for cell reprogramming, in particular to prime for chemotherapy or immunotherapy.
    Type: Application
    Filed: October 3, 2016
    Publication date: October 4, 2018
    Applicants: PIERRE FABRE MEDICAMENT, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Yoann MENON, Christophe LONG, François SAUTEL, Paola B. ARIMONDO